Literature DB >> 29128059

Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.

Vignan Manne1, Priya Handa1, Kris V Kowdley2.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) encompasses a spectrum of liver disorders ranging from hepatic steatosis to nonalcoholic steatohepatitis (NASH) and ultimately may lead to cirrhosis. Hepatic steatosis or fatty liver is defined as increased accumulation of lipids in hepatocytes and results from increased production or reduced clearance of hepatic triglycerides or fatty acids. Fatty liver can progress to NASH in a significant proportion of subjects. NASH is a necroinflammatory liver disease governed by multiple pathways that are not completely elucidated. This review describes the main mechanisms that have been reported to contribute to the pathophysiology of NAFLD and NASH.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fibrosis; Genetic factors; Inflammation; Nonalcoholic fatty liver disease (NAFLD); Nonalcoholic steatohepatitis (NASH)

Mesh:

Substances:

Year:  2017        PMID: 29128059     DOI: 10.1016/j.cld.2017.08.007

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  82 in total

1.  Nanoformulated SOD1 ameliorates the combined NASH and alcohol-associated liver disease partly via regulating CYP2E1 expression in adipose tissue and liver.

Authors:  Thiyagarajan Gopal; Narendra Kumar; Curtis Perriotte-Olson; Carol A Casey; Terrence M Donohue; Edward N Harris; Geoffrey Talmon; Alexander V Kabanov; Viswanathan Saraswathi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-13       Impact factor: 4.052

2.  Hepatic Steatosis Is Associated with Elevated Serum Iron in Patients with Obesity and Improves after Laparoscopic Sleeve Gastrectomy.

Authors:  Bingwei Ma; Hang Sun; Bing Zhu; Shilin Wang; Lei Du; Xingchun Wang; Shen Qu
Journal:  Obes Facts       Date:  2020-12-22       Impact factor: 3.942

3.  Screening of non-alcoholic steatohepatitis (NASH)-related datasets and identification of NASH-related genes.

Authors:  Ming-Jiang Liu; Hu Jin; Yu-Bing Chen; Jing-Jing Yu; Zhen-Ya Guo; Song-Qing He; Yong-Lian Zeng
Journal:  Int J Clin Exp Pathol       Date:  2021-05-15

4.  Long-term intake of 9-PAHPA or 9-OAHPA modulates favorably the basal metabolism and exerts an insulin sensitizing effect in obesogenic diet-fed mice.

Authors:  Melha Benlebna; Laurence Balas; Béatrice Bonafos; Laurence Pessemesse; Gilles Fouret; Claire Vigor; Sylvie Gaillet; Jacques Grober; Florence Bernex; Jean-François Landrier; Ondrej Kuda; Thierry Durand; Charles Coudray; François Casas; Christine Feillet-Coudray
Journal:  Eur J Nutr       Date:  2020-09-28       Impact factor: 5.614

Review 5.  A Fad too Far? Dietary Strategies for the Prevention and Treatment of NAFLD.

Authors:  Mary P Moore; Rory P Cunningham; Ryan J Dashek; Justine M Mucinski; R Scott Rector
Journal:  Obesity (Silver Spring)       Date:  2020-09-06       Impact factor: 5.002

Review 6.  Mediterranean diet for patients with non-alcoholic fatty liver disease, a systematic review and meta-analysis of observational and clinical investigations.

Authors:  Masoumeh Akhlaghi; Maryam Ghasemi-Nasab; Maryamsadat Riasatian
Journal:  J Diabetes Metab Disord       Date:  2020-02-17

7.  Mice with Fabp4-Cre ablation of Arid5b are resistant to diet-induced obesity and hepatic steatosis.

Authors:  Robert H Whitson; Shu-Lian Li; Guoxiang Zhang; Garrett P Larson; Keiichi Itakura
Journal:  Mol Cell Endocrinol       Date:  2021-03-20       Impact factor: 4.102

Review 8.  Nonalcoholic Fatty Liver Disease.

Authors:  Lingling Ding; Yvonne Oligschlaeger; Ronit Shiri-Sverdlov; Tom Houben
Journal:  Handb Exp Pharmacol       Date:  2022

Review 9.  Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer.

Authors:  Yongyan Chen; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2020-10-12       Impact factor: 11.530

10.  Ginkgo biloba Extract 50 (GBE50) Ameliorates Insulin Resistance, Hepatic Steatosis and Liver Injury in High Fat Diet-Fed Mice.

Authors:  Liu Li; Li Yang; Feng Yang; Xin-Lan Zhao; Shengjiang Xue; Fang-Hua Gong
Journal:  J Inflamm Res       Date:  2021-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.